These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 11549529

  • 1. Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone.
    Calhoun WJ, Nelson HS, Nathan RA, Pepsin PJ, Kalberg C, Emmett A, Rickard KA, Dorinsky P.
    Am J Respir Crit Care Med; 2001 Sep 01; 164(5):759-63. PubMed ID: 11549529
    [Abstract] [Full Text] [Related]

  • 2. Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma.
    Pearlman DS, White MV, Lieberman AK, Pepsin PJ, Kalberg C, Emmett A, Bowers B, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2002 Feb 01; 88(2):227-35. PubMed ID: 11868930
    [Abstract] [Full Text] [Related]

  • 3. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Oct 01; 93(4):351-9. PubMed ID: 15521371
    [Abstract] [Full Text] [Related]

  • 4. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
    Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Proprionate Clinical Research Study Group.
    J Allergy Clin Immunol; 2001 Mar 01; 107(3):461-8. PubMed ID: 11240946
    [Abstract] [Full Text] [Related]

  • 5. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Dec 01; 93(6):581-8. PubMed ID: 15609769
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 01; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 7. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.
    Ann Allergy Asthma Immunol; 2004 Jun 01; 92(6):641-8. PubMed ID: 15237766
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2002 Jun 01; 20(13):909-18. PubMed ID: 12381242
    [Abstract] [Full Text] [Related]

  • 9. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
    Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil K.
    J Allergy Clin Immunol; 2000 Dec 01; 106(6):1088-95. PubMed ID: 11112891
    [Abstract] [Full Text] [Related]

  • 10. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 Dec 01; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 11. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
    Ann Allergy Asthma Immunol; 1999 Mar 01; 82(3):257-65. PubMed ID: 10094216
    [Abstract] [Full Text] [Related]

  • 12. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr 01; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 13. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
    Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.
    J Allergy Clin Immunol; 2000 Jun 01; 105(6 Pt 1):1108-16. PubMed ID: 10856143
    [Abstract] [Full Text] [Related]

  • 14. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA, Paluga I, Goldfrad CH, Duggan MT, Barnes N.
    J Asthma; 2007 Jun 01; 44(6):437-41. PubMed ID: 17654129
    [Abstract] [Full Text] [Related]

  • 15. Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma.
    Pieters WR, Wilson KK, Smith HC, Tamminga JJ, Sondhi S.
    Treat Respir Med; 2005 Jun 01; 4(2):129-38. PubMed ID: 15813665
    [Abstract] [Full Text] [Related]

  • 16. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.
    J Allergy Clin Immunol; 2004 Feb 01; 113(2):245-51. PubMed ID: 14767437
    [Abstract] [Full Text] [Related]

  • 17. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov 01; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 18. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2007 Jan 01; 119(1):64-72. PubMed ID: 17140647
    [Abstract] [Full Text] [Related]

  • 19. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
    Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
    [Abstract] [Full Text] [Related]

  • 20. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
    Eur Ann Allergy Clin Immunol; 2003 Nov 29; 35(9):356-62. PubMed ID: 14716965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.